These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 31077284)

  • 1. Decoy Receptor 3 Expression Is Associated With Wild-Type EGFR Status, Poor Differentiation of Tumor, and Unfavorable Patient Outcome.
    Chang WC; Yeh YC; Ho HL; Hsieh SL; Chou TY
    Am J Clin Pathol; 2019 Jul; 152(2):207-216. PubMed ID: 31077284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Death decoy receptor overexpression and increased malignancy risk in colorectal cancer.
    Zong L; Chen P; Wang DX
    World J Gastroenterol; 2014 Apr; 20(15):4440-5. PubMed ID: 24764685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Relationship between expression of decoy receptor 3 and apoptosis in hepatocellular carcinoma].
    Chen G; Luo DZ; Wang Y; Liao ZL; Zhang MY
    Zhonghua Bing Li Xue Za Zhi; 2007 Feb; 36(2):113-7. PubMed ID: 17493386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decoy receptor 3 is a prognostic factor in renal cell cancer.
    Macher-Goeppinger S; Aulmann S; Wagener N; Funke B; Tagscherer KE; Haferkamp A; Hohenfellner M; Kim S; Autschbach F; Schirmacher P; Roth W
    Neoplasia; 2008 Oct; 10(10):1049-56. PubMed ID: 18813347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decoy receptor 3 is involved in epidermal keratinocyte commitment to terminal differentiation via EGFR and PKC activation.
    Wu NL; Huang DY; Hsieh SL; Dai YS; Lin WW
    Exp Mol Med; 2022 Apr; 54(4):542-551. PubMed ID: 35478210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plakophilin-2 accelerates cell proliferation and migration through activating EGFR signaling in lung adenocarcinoma.
    Hao XL; Tian Z; Han F; Chen JP; Gao LY; Liu JY
    Pathol Res Pract; 2019 Jul; 215(7):152438. PubMed ID: 31126818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific expression of MUC21 in micropapillary elements of lung adenocarcinomas - Implications for the progression of EGFR-mutated lung adenocarcinomas.
    Matsumura M; Okudela K; Nakashima Y; Mitsui H; Denda-Nagai K; Suzuki T; Arai H; Umeda S; Tateishi Y; Koike C; Kataoka T; Irimura T; Ohashi K
    PLoS One; 2019; 14(4):e0215237. PubMed ID: 30973916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EGFR-driven up-regulation of decoy receptor 3 in keratinocytes contributes to the pathogenesis of psoriasis.
    Wu NL; Huang DY; Hsieh SL; Hsiao CH; Lee TA; Lin WW
    Biochim Biophys Acta; 2013 Oct; 1832(10):1538-48. PubMed ID: 23707413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic significance of overexpression of the decoy receptor for Fas ligand (DcR3) in patients with gastric carcinomas.
    Takahama Y; Yamada Y; Emoto K; Fujimoto H; Takayama T; Ueno M; Uchida H; Hirao S; Mizuno T; Nakajima Y
    Gastric Cancer; 2002; 5(2):61-8. PubMed ID: 12111580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High DcR3 expression predicts stage pN2 in gastric cancer.
    Wu Y; Guo E; Yu J; Xie Q; Chen J
    Hepatogastroenterology; 2007; 54(79):2172-6. PubMed ID: 18251184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High DcR3 expression predicts stage pN2-3 in gastric cancer.
    Wu Y; Guo E; Yu J; Xie Q
    Am J Clin Oncol; 2008 Feb; 31(1):79-83. PubMed ID: 18376232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decoy receptor 3 enhances tumor progression via induction of tumor-associated macrophages.
    Tai SK; Chang HC; Lan KL; Lee CT; Yang CY; Chen NJ; Chou TY; Tarng DC; Hsieh SL
    J Immunol; 2012 Mar; 188(5):2464-71. PubMed ID: 22287720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Over-expression of decoy receptor 3 in gastric precancerous lesions and carcinoma.
    Chen G; Luo D
    Ups J Med Sci; 2008; 113(3):297-304. PubMed ID: 18991242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ascites from epithelial ovarian cancer contain high levels of functional decoy receptor 3 (DcR3) and is associated with platinum resistance.
    Connor JP; Felder M
    Gynecol Oncol; 2008 Nov; 111(2):330-5. PubMed ID: 18723214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decoy receptor 3: an endogenous immunomodulator in cancer growth and inflammatory reactions.
    Hsieh SL; Lin WW
    J Biomed Sci; 2017 Jun; 24(1):39. PubMed ID: 28629361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiological study of HER-2 mutations among EGFR wild-type lung adenocarcinoma patients in China.
    Li X; Zhao C; Su C; Ren S; Chen X; Zhou C
    BMC Cancer; 2016 Oct; 16(1):828. PubMed ID: 27793199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Idiopathic pulmonary fibrosis fibroblasts become resistant to Fas ligand-dependent apoptosis via the alteration of decoy receptor 3.
    Im J; Kim K; Hergert P; Nho RS
    J Pathol; 2016 Sep; 240(1):25-37. PubMed ID: 27218286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing DcR3 expression in relation to survivin and other prognostic factors in B cell non-Hodgkin's lymphoma.
    Bedewy AM; Elgammal MM; Bedewy MM; El-Maghraby SM
    Ann Hematol; 2013 Oct; 92(10):1359-67. PubMed ID: 23652586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decoy receptor 3: a pleiotropic immunomodulator and biomarker for inflammatory diseases, autoimmune diseases and cancer.
    Lin WW; Hsieh SL
    Biochem Pharmacol; 2011 Apr; 81(7):838-47. PubMed ID: 21295012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The expression of death decoy receptor 3 was increased in the patients with primary Sjögren's syndrome.
    Liu J; Zhao Z; Zou Y; Zhang M; Zhou Y; Li Y; Pang Z; Jin W
    Clin Rheumatol; 2015 May; 34(5):879-85. PubMed ID: 25564309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.